Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new arimidex clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on arimidex
- Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Aromasin vs Arimidex Study As Initial Hormonal Therapy in Postmenopausal Women With Advanced/Recurrent Breast Cancer
Status: Recruiting, Condition Summary: Breast Neoplasms - Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer; Breast Neoplasms - A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (Study P03480AM5)
Status: Recruiting, Condition Summary: Breast Cancer - An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment
Status: Recruiting, Condition Summary: Breast Cancer - Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Status: Active, not recruiting, Condition Summary: Breast Cancer - Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
Status: Recruiting, Condition Summary: Breast Cancer - Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Exemestane or Anastrozole in Treating Postmenopausal Women With Hormone Receptor-Positive Primary Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Anastrozole With or Without Lonafarnib in Treating Postmenopausal Women With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
Status: Active, not recruiting, Condition Summary: Breast Cancer - Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
Status: Active, not recruiting, Condition Summary: Metastatic Breast Cancer - Trial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
Status: Completed, Condition Summary: Breast Cancer - PROACT - Pre-Operative Arimidex Compared To Tamoxifen
Status: Completed, Condition Summary: Breast Cancer - Second Line Breast Cancer Trial
Status: Completed, Condition Summary: Advanced Breast Cancer - Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Status: Active, not recruiting, Condition Summary: Puberty, Precocious - Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or Placebo
Status: Completed, Condition Summary: Seizure Disorder; Hypogonadism; Erectile Dysfunction - Breast Cancer Tumor Care Observational Programme
Status: Recruiting, Condition Summary: Post Menopausal; Arthralgia - Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
Status: Active, not recruiting, Condition Summary: Breast Cancer - Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
Status: Recruiting, Condition Summary: Breast Cancer